'Good autoantibodies' could help against long COVID natimmunol
. We are grateful to M. Baggiolini for mentoring, support and fruitful discussions. This work was supported by the Swiss Vaccine Research Institute , the National Institutes of Health ; the European Union’s Horizon 2020 research and innovation programme ; BRIDGE no.
Shanbhag, Milos Matkovic, Jacques Moritz, Chiara Toscano, Elaheh Ghovehoud, Gabriela Danelon-Sargenti, Simone Moro, Tao Gong, Pietro Piffaretti, Filippo Bianchini, Virginia Crivelli, Lucie Podešvová, Mattia Pedotti, David Jarrossay, Jacopo Sgrignani, Sylvia Thelen, Luca Varani, Marcus Thelen, Mariagrazia Uguccioni & Davide F.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
SARS-CoV-2 Antibody Dynamics in Healthcare Workers after mRNA VaccinationSince the emergence of SARS-CoV-2, maintaining healthcare worker (HCW) health and safety has been fundamental to responding to the global pandemic. Vaccination with mRNA-base vaccines targeting SARS-CoV-2 spike protein has emerged as a key strategy in reducing HCW susceptibility to SARS-CoV-2, however, neutralizing antibody responses subside with time and may be influenced by many variables. We sought to understand the dynamics between vaccine products, prior clinical illness from SARS-CoV-2, and incidence of vaccine-associated adverse reactions on antibody decay over time in HCWs at a university medical center. A cohort of 296 HCWs received standard two-dose vaccination with either bnt162b2 (Pfizer/BioNTech) or mRNA-1273 (Moderna) and were evaluated after two, six, and nine months. Subjects were grouped by antibody decay curve into steep antibody decliners gentle decliners. Vaccination with mRNA-1273 led to more sustained antibody responses compared to bnt162b2. Subjects experiencing vaccine-associated symptoms were more likely to experience a more prolonged neutralizing antibody response. Subjects with clinical SARS-CoV-2 infection prior to vaccination were more likely to experience vaccination-associated symptoms after first vaccination and were more likely to have a more blunted antibody decay. Understanding factors associated with vaccine efficacy may assist clinicians in determining appropriate vaccine strategies in HCWs.
Weiterlesen »
Trial emulation shows the effectiveness of the COVID-19 vaccine in improving long COVID symptomsTrial emulation shows the effectiveness of the COVID-19 vaccine in improving long COVID symptoms univ_spn COVID19 SARSCoV2 LongCOVID Vaccine Effectiveness
Weiterlesen »
Hancock told aides he wanted to 'frighten the pants off everyone' about COVID, leaked messages sayThe exchanges are among more than 100,000 messages leaked by journalist Isabel Oakeshott, who was given them by Mr Hancock while they were collaborating on his memoir.
Weiterlesen »
Kate Garraway says husband Derek’s Covid journey has been ‘tough financially’Good Morning Britain presenter Kate Garraway has opened up about how caring for her husband Derek Draper, who fell ill with Covid-19 in March 2020, has been 'tough financially'
Weiterlesen »
Covid: Dog behaviour problems linked to lockdownsExperts say some dogs have not been socialised properly which has led to behavioural issues🐕🐕 USPCA_Official
Weiterlesen »
Need to ‘frighten the pants’ off people with new Covid variant, said HancockLatest set of WhatsApp exchanges show how Mr Hancock and others discussed how to use an announcement about the Kent variant of the virus to scare the public
Weiterlesen »